Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes [PDF]
Cappellini, MD+4 more
core
Deferiprone or deferasirox for cardiac siderosis in beta-thalassemia major
Khaled M. Musallam, Alì Taher
openalex +2 more sources
Tb doped carbon dots as a platform for fluorescence ratiometric and colorimetric sensor for deferasirox. [PDF]
Latifi F, Amjadi M, Hallaj T, Alavi SMS.
europepmc +1 more source
Long-term use of deferiprone significantly enhances left-ventricular ejection function in thalassemia major patients [PDF]
Calvaruso, G+19 more
core +1 more source
Drug-induced liver injury from Deferasirox in a pediatric patient with hereditary spherocytosis: A case report. [PDF]
Talwar S+5 more
europepmc +1 more source
Use of deferasirox, an iron chelator, to overcome imatinib resistance of chronic myeloid leukemia cells [PDF]
Dae Sik Kim+4 more
openalex +1 more source
Hepatic and renal functions of paediatric patients with thalassaemia: a cross-sectional study from two large thalassaemia centres in Sri Lanka. [PDF]
Wijenayake W+7 more
europepmc +1 more source